Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma

Human Pathology

Volumn 45, Issue 2, 2014, Pages 259-267

  Aung, Phyu P ^a   Liu, Yen Chun ^a   Ballester, Leomar Y ^a   Robbins, Paul F ^a   Rosenberg, Steven A ^a   Lee, Chyi Chia Richard ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer testis antigen; Immunotherapy; Melanoma; NY ESO 1

Indexed keywords

NY ESO 1 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; CUTANEOUS MELANOMA; DESMOPLASTIC MELANOMA; EPITHELIOID CELL; EPITHELIOID MELANOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; METASTATIC MELANOMA; PRIMARY MELANOMA; PRIMARY TUMOR; RHABDOID MELANOMA; SPINDLE CELL;

CANCER TESTIS ANTIGEN; IMMUNOTHERAPY; MELANOMA; NY-ESO-1;

ADULT; AGED; ANTIGENS, NEOPLASM; FEMALE; HUMANS; MALE; MELANOMA; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM METASTASIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84892798662     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.05.029     Document Type: Article

References (19)

1. D. Ivan, and V.G. Prieto Use of immunohistochemistry in the diagnosis of melanocytic lesions: applications and pitfalls Future Oncol 6 2010 1163 1175
2. E.F. Velazquez, A.A. Jungbluth, and M. Yancovitz et al. Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM): correlation with prognostic factors Cancer Immun 7 2007 11
3. M. Lüftl, G. Schuler, and A.A. Jungbluth Melanoma or not? Cancer testis antigens may help Br J Dermatol 151 2004 1213 1218
4. P.F. Robbins, R.A. Morgan, and S.A. Feldman et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1 J Clin Oncol 29 2011 917 924
5. J.P. Lai, P.F. Robbins, and M. Raffeld et al. NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis Mod Pathol 25 2012 854 858
6. J. Kawada, H. Wada, and M. Isobe et al. Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination Int J Cancer 130 2012 584 592
7. F. de Carvalho, A.L. Vettore, and R.J. Inaoka et al. Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy Cancer Immun 11 2011 1
8. A. Walter, M.J. Barysch, and S. Behnke et al. Cancer-testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas Clin Cancer Res 16 2010 3562 3570
9. S. Gnjatic, Y. Cao, and U. Reichelt et al. NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer Int J Cancer 127 2010 381 393
10. Y.T. Chen, A. Chadburn, and P. Lee et al. Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas Proc Natl Acad Sci USA 107 2010 3093 3098
11. M.E. Dudley, J.C. Yang, and R. Sherry et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens J Clin Oncol 26 2008 5233 5239
12. S.A. Rosenberg, and M.E. Dudley Adoptive cell therapy for the treatment of patients with metastatic melanoma Curr Opin Immunol 21 2009 233 240
13. + T cells in the treatment of metastatic melanoma Nat Clin Pract Oncol 5 2008 696 697
14. S.A. Rosenberg, J.C. Yang, and R.M. Sherry et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T cell transfer immunotherapy Clin Cancer Res 17 2011 4550 4557
15. M.J. Scanlan, A.J. Simpson, and L.J. Old The cancer/testis genes: review, standardization, and commentary Cancer Immun 4 2004 1
16. D. Jäger, E. Jäger, and A. Knuth Immune responses to tumour antigens: implications for antigen-specific immunotherapy of cancer J Clin Pathol 54 2001 669 674
17. M.J. Scanlan, A.O. Güre, and A.A. Jungbluth et al. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy Immunol Rev 188 2002 22 32
18. Y. Feng, J. Gao, and M. Yang When MAGE meets RING: insights into biological functions of MAGE proteins Protein Cell 2 2011 7 12
19. H.A. Smith, and D.G. McNeel The SSX family of cancer-testis antigens as target proteins for tumor therapy Clin Dev Immunol 2010 2010 150591